Logo image of ASST

ASSET ENTITIES INC-B (ASST) Stock Fundamental Analysis

NASDAQ:ASST - Nasdaq - US04541A2042 - Common Stock - Currency: USD

4.12  -0.24 (-5.5%)

After market: 4.16 +0.04 (+0.97%)

Fundamental Rating

2

Overall ASST gets a fundamental rating of 2 out of 10. We evaluated ASST against 97 industry peers in the Media industry. While ASST seems to be doing ok healthwise, there are quite some concerns on its profitability. ASST has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

In the past year ASST has reported negative net income.
ASST had a negative operating cash flow in the past year.
In multiple years ASST reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: ASST reported negative operating cash flow in multiple years.
ASST Yearly Net Income VS EBIT VS OCF VS FCFASST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 0 -2M -4M -6M

1.2 Ratios

ASST has a Return On Assets of -134.56%. This is amonst the worse of the industry: ASST underperforms 91.84% of its industry peers.
With a Return On Equity value of -148.23%, ASST is not doing good in the industry: 80.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -134.56%
ROE -148.23%
ROIC N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ASST Yearly ROA, ROE, ROICASST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 -100 -200 -300 -400

1.3 Margins

ASST does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ASST Yearly Profit, Operating, Gross MarginsASST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

6

2. Health

2.1 Basic Checks

ASST does not have a ROIC to compare to the WACC, probably because it is not profitable.
ASST has more shares outstanding than it did 1 year ago.
ASST has a worse debt/assets ratio than last year.
ASST Yearly Shares OutstandingASST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ASST Yearly Total Debt VS Total AssetsASST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 1M 2M 3M

2.2 Solvency

ASST has an Altman-Z score of 81.92. This indicates that ASST is financially healthy and has little risk of bankruptcy at the moment.
ASST's Altman-Z score of 81.92 is amongst the best of the industry. ASST outperforms 98.98% of its industry peers.
ASST has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of ASST (0.10) is better than 74.49% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 81.92
ROIC/WACCN/A
WACC9.02%
ASST Yearly LT Debt VS Equity VS FCFASST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M

2.3 Liquidity

A Current Ratio of 9.72 indicates that ASST has no problem at all paying its short term obligations.
With an excellent Current ratio value of 9.72, ASST belongs to the best of the industry, outperforming 98.98% of the companies in the same industry.
ASST has a Quick Ratio of 9.72. This indicates that ASST is financially healthy and has no problem in meeting its short term obligations.
ASST has a better Quick ratio (9.72) than 98.98% of its industry peers.
Industry RankSector Rank
Current Ratio 9.72
Quick Ratio 9.72
ASST Yearly Current Assets VS Current LiabilitesASST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

1

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 2.64% over the past year.
Looking at the last year, ASST shows a very strong growth in Revenue. The Revenue has grown by 99.44%.
ASST shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -8.60% yearly.
EPS 1Y (TTM)2.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.22%
Revenue 1Y (TTM)99.44%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%36.86%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ASST Yearly Revenue VS EstimatesASST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 200K 400K 600K 800K

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ASST. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ASST Price Earnings VS Forward Price EarningsASST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ASST Per share dataASST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -0.5 -1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ASST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ASSET ENTITIES INC-B

NASDAQ:ASST (7/25/2025, 8:00:00 PM)

After market: 4.16 +0.04 (+0.97%)

4.12

-0.24 (-5.5%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.33%
Inst Owner Change17.52%
Ins Owners2.7%
Ins Owner Change-2.73%
Market Cap68.35M
AnalystsN/A
Price TargetN/A
Short Float %23.98%
Short Ratio0.18
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 100.59
P/FCF N/A
P/OCF N/A
P/B 15.08
P/tB 16.98
EV/EBITDA N/A
EPS(TTM)-1.45
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.35
FCFYN/A
OCF(TTM)-0.33
OCFYN/A
SpS0.04
BVpS0.27
TBVpS0.24
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -134.56%
ROE -148.23%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-177.91%
ROA(5y)-95.32%
ROE(3y)-273.24%
ROE(5y)-137.03%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.14
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 9.72
Quick Ratio 9.72
Altman-Z 81.92
F-Score5
WACC9.02%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%74.22%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)99.44%
Revenue growth 3Y-8.6%
Revenue growth 5YN/A
Sales Q2Q%36.86%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-27.2%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-28.69%
OCF growth 3YN/A
OCF growth 5YN/A